Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | PDE4A | P27815 | 1/20 | 0.52 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.52 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 5/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | G6PD | P11413 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811025 | 0.97 | ALDH1A1 (0.50) | ALDH1A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL15317151 | 0.92 | PDE4A (0.44) | ALDH1A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL11496731 | 0.87 | ALDH1A1 (0.63) | ALDH1A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2138144 | 0.84 | ALDH1A1 (0.60) | ALDH1A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL27765191 | 0.84 | ALDH1A1 (0.60) | ALDH1A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL1912056 | 0.84 | ACHE (0.52) | ALDH1A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL14579656 | 0.81 | TNFSF11 (0.61) | ALDH1A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6012957 | 0.77 | TSHR (0.41) | ALDH1A1ACHEMAPTCYP3A4NQO2 | |
| SCHEMBL30587865 | 0.77 | TSHR (0.41) | ALDH1A1ACHEMAPTCYP3A4NQO2 | |
| SCHEMBL17752819 | 0.76 | ALDH1A1 (0.41) | ALDH1A1PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7884249-B2 | oxidizing a diol derivative with an oxidizing agent such as osmium tetraoxide to form 6,13-ethanopentacene-6,13-dione | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-7884249-B2 | oxidizing a diol derivative with an oxidizing agent such as osmium tetraoxide to form 6,13-ethanopentacene-6,13-dione | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-12-24 | — | — | US | disclosed |
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-12-24 | — | — | US | disclosed |
| US-7601478-B2 | Bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same | CANON KABUSHIKI KAISHA (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7601478-B2 | Bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same | CANON KABUSHIKI KAISHA (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7588959-B2 | Organic field effect transistor and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
| US-7588959-B2 | Organic field effect transistor and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | C9, C5, RNF168 | ALDH1A1 946/4885PDE4A 4079/4885PDE4B 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.